Frankfurt - Delayed Quote EUR
Sartorius Stedim Biotech S.A. (56S1.F)
192.00
0.00
(0.00%)
As of 8:03:48 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 12 | 12 |
| Avg. Estimate | 718.15M | 731.83M | 3B | 3.34B |
| Low Estimate | 666.9M | 714.62M | 2.94B | 3.24B |
| High Estimate | 747.57M | 748.86M | 3.05B | 3.42B |
| Year Ago Sales | 706.4M | 655.4M | 2.78B | 3B |
| Sales Growth (year/est) | 1.66% | 11.66% | 7.96% | 11.15% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 56S1.F | -- | -- | -- | -- |
| S&P 500 | 12.65% | 2.48% | 7.35% | 14.09% |
Upgrades & Downgrades
| Downgrade | Societe Generale: Buy to Hold | 10/1/2021 |